Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common pathology subtype of lung cancer. In recent years, immunotherapy, targeted therapy and chemotherapeutics conferred a certain curative effects. However, the effect and prognosis of LUAD patients are different, and the efficacy of existing LUAD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Yang, Zhao, Bin, Wang, Yuzhen, Li, Lina, Li, Jingjin, Li, Xu, Chang, Linhan, Chen, Qian, Liao, Zijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923649/
https://www.ncbi.nlm.nih.gov/pubmed/33648465
http://dx.doi.org/10.1186/s12885-021-07911-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923649/
https://www.ncbi.nlm.nih.gov/pubmed/33648465
http://dx.doi.org/10.1186/s12885-021-07911-8

Ejemplares similares